Skye Bioscience, Inc. (SKYE) Stock Total Returns
Growth of $10,000 chart
2021-06-03 to 2026-06-03 to
$
%
%
Loading chart…
Investment Performance
Final Value
$162
Total Return
-98.38%
CAGR
-56.16%
Dividends
$0.00
Yield on Cost
0.00%
Rolling Returns
1-Month (21 Trading Days)
| Average | +1.10% |
| Median | -9.64% |
| Best | +523.67% |
| Worst | -68.43% |
| % of Windows Positive | 33.0% |
1-Year (252 Trading Days)
| Average | -19.92% |
| Median | -52.62% |
| Best | +308.39% |
| Worst | -91.16% |
| % of Windows Positive | 21.8% |
3-Year (756 Trading Days)
| Average | -75.04% |
| Median | -77.36% |
| Best | -20.83% |
| Worst | -93.78% |
| % of Windows Positive | 0.0% |
Risk Metrics
| Maximum Drawdown | -98.79% |
| Average Drawdown | -83.47% |
| Drawdown Duration | 1253 Trading Days (Unrecovered) |
| Sortino Ratio | 0.02 |
| Calmar Ratio | -0.57 |
| CVaR (5%) | -15.88% |
Yearly Returns
| Year | Percentage | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|
| 2026 partial | +2.58% (+6.24% ann.) | +$258.40 | $0.00 | $0.00 | $0.00 |
| 2025 | -73.51% | $7351.13 | $0.00 | $0.00 | $0.00 |
| 2024 | +4.06% | +$405.98 | $0.00 | $0.00 | $0.00 |
| 2023 | -32.01% | $3200.97 | $0.00 | $0.00 | $0.00 |
| 2022 | -69.23% | $6922.50 | $0.00 | $0.00 | $0.00 |
| 2021 | +30.01% | +$3001.36 | $0.00 | $0.00 | $0.00 |
| 2020 | -69.47% | $6946.70 | $0.00 | $0.00 | $0.00 |
| 2019 | -67.25% | $6725.05 | $0.00 | $0.00 | $0.00 |
| 2018 | +163.16% | +$16315.71 | $0.00 | $0.00 | $0.00 |
| 2017 | -49.67% | $4966.90 | $0.00 | $0.00 | $0.00 |
| 2016 | -56.86% | $5685.71 | $0.00 | $0.00 | $0.00 |
| 2015 partial | -90.97% (-91.34% ann.) | $9096.77 | $0.00 | $0.00 | $0.00 |
Market Regimes
about| Regime | Period | Percentage | Annual | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|---|---|
| Secular stagnation / QE / low inflation / duration bull partial | January 6, 2015 – February 19, 2020 | -98.84% | -58.12% | $9883.87 | $0.00 | $0.00 | $0.00 |
| Pandemic shock / liquidity crash | February 20, 2020 – March 23, 2020 | -17.45% | -88.79% | $1744.62 | $0.00 | $0.00 | $0.00 |
| Policy bazooka / monetary euphoria | March 24, 2020 – November 6, 2020 | -47.30% | -64.32% | $4729.79 | $0.00 | $0.00 | $0.00 |
| Reopening reflation / fiscal boom / supply bottlenecks | November 9, 2020 – November 29, 2021 | +78.95% | +73.69% | +$7895.17 | $0.00 | $0.00 | $0.00 |
| Inflation shock / duration crash / aggressive tightening | November 30, 2021 – November 9, 2022 | -70.88% | -73.02% | $7088.48 | $0.00 | $0.00 | $0.00 |
| Disinflation rebound / AI-led narrow bull / higher-for-longer | November 10, 2022 – September 17, 2024 | -8.19% | -4.50% | $818.73 | $0.00 | $0.00 | $0.00 |
| Disinflationary easing / resilient growth / AI capex under oil-shock test partial | September 18, 2024 – June 3, 2026 | -85.32% | -67.54% | $8532.35 | $0.00 | $0.00 | $0.00 |
Dividend History
| Date | Per Share | Yield % |
|---|---|---|
| Total | 0 payments |
No dividends recorded.
All calculations use split-adjusted closing prices. Dividends are reinvested on the ex-dividend date at that day's closing price.
For each rolling window, returns are calculated at every possible starting point:
return = (value[i] ÷ value[i − windowSize] − 1) × 100
- Windows
- 1-month = 21 trading days, 1-year = 252 trading days, 3-year = 756 trading days.
- Statistics
- Average: arithmetic mean. Median: middle value when sorted. Best / Worst: max and min. % Positive: share of windows with return > 0.
The series is segmented by calendar year:
return = (endValue ÷ startValue − 1) × 100
startValue is the last value of the prior year (or the first value for the initial year). Partial first/last years are flagged. Dividends, taxes, and transaction costs are scaled proportionally to the initial investment.